Fecal transplant study for type 2 diabetes and Hashimoto's thyroiditis
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests if a fecal microbiota transplant can help people with both type 2 diabetes and Hashimoto's thyroiditis. It aims to see if changing gut bacteria can improve blood sugar and thyroid health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have type 2 diabetes
- You have Hashimoto's thyroiditis (positive antibodies and thyroid ultrasound changes)
- Your diabetes and thyroid medications have been the same for at least 3 months
- You have not taken antibiotics, probiotics, or prebiotics in the last 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This pilot study tests whether a fecal microbiota transplant (putting healthy donor stool into the colon) can improve health in people with type 2 diabetes and stable coronary artery disease. It will help researchers see if changing gut bacteria can help manage both conditions.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This study tests if taking capsules with processed donor stool can help preserve insulin-making cells in people recently diagnosed with type 1 diabetes. The treatment aims to slow the loss of insulin production.
This Phase 2 study tests whether a fecal microbiota transplant (a processed transplant of gut bacteria) after an allogeneic bone marrow transplant is safe and helpful. Participants may benefit by improving recovery in the gut microbiome during the post-transplant period.
This trial tests whether a treatment called washed microbiota transplantation (putting healthy bacteria into your gut) can help with stomach and bowel problems caused by type 2 diabetes. It aims to see if it's safe and if it improves symptoms.
This Phase 1/2 study tests whether a fecal microbiome transplant (FMT) can reduce active inflammation in people with Crohn’s disease. It’s designed for people who currently have signs of active bowel inflammation and can attend regular procedure visits.
Hear when a new Autoimmune Thyroid Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.